These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19817713)

  • 21. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review.
    Singh K; Cheung BM; Xu A
    Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546
    [No Abstract]   [Full Text] [Related]  

  • 22. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
    Gardai SJ; Mao W; Schüle B; Babcock M; Schoebel S; Lorenzana C; Alexander J; Kim S; Glick H; Hilton K; Fitzgerald JK; Buttini M; Chiou SS; McConlogue L; Anderson JP; Schenk DB; Bard F; Langston JW; Yednock T; Johnston JA
    PLoS One; 2013; 8(8):e71634. PubMed ID: 24058406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy: An emerging treatment option for neurodegenerative diseases.
    Mukherjee A; Biswas S; Roy I
    Drug Discov Today; 2024 May; 29(5):103974. PubMed ID: 38555032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers for neurodegenerative diseases.
    Hansson O
    Nat Med; 2021 Jun; 27(6):954-963. PubMed ID: 34083813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF Cytokines in Aging, Multiple Sclerosis, and Dementia.
    Hu WT; Howell JC; Ozturk T; Gangishetti U; Kollhoff AL; Hatcher-Martin JM; Anderson AM; Tyor WR
    Front Immunol; 2019; 10():480. PubMed ID: 30930904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases.
    Sarkar S; Roy D; Chatterjee B; Ghosh R
    Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
    Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
    Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of IL-15 in central nervous system disorders.
    Rentzos M; Rombos A
    Acta Neurol Scand; 2012 Feb; 125(2):77-82. PubMed ID: 21615353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.
    Maguire-Zeiss KA; Federoff HJ
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):298-308. PubMed ID: 18931916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
    Blennow K; Biscetti L; Eusebi P; Parnetti L
    Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
    Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
    Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
    Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
    J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders.
    Wei TY; Fu Y; Chang KH; Lin KJ; Lu YJ; Cheng CM
    Trends Biotechnol; 2018 Mar; 36(3):290-303. PubMed ID: 29242004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.
    Whitehouse PJ; Vale WW; Zweig RM; Singer HS; Mayeux R; Kuhar MJ; Price DL; De Souza EB
    Neurology; 1987 Jun; 37(6):905-9. PubMed ID: 3495748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.
    Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.